Estela Paz-Artal Selected Research

Infections

12/2021	Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.
1/2021	Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
10/2016	Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.
2/2016	High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipients.
10/2009	Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation.
9/2006	Familial hemophagocytic lymphohistiocytosis in an adult patient homozygous for A91V in the perforin gene, with tuberculosis infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Estela Paz-Artal Research Topics

Disease

18	COVID-19 01/2023 - 09/2020
10	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2023 - 06/2012
9	Thrombosis (Thrombus) 12/2023 - 01/2014
6	Infections 12/2021 - 09/2006
4	Virus Diseases (Viral Diseases) 01/2023 - 02/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2014
2	Breakthrough Infections 01/2023 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2022
2	Neoplasms (Cancer) 01/2022 - 12/2020
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 08/2015
2	Pneumonia (Pneumonitis) 04/2021 - 04/2021
2	Cytokine Release Syndrome 04/2021 - 04/2021
2	Opportunistic Infections (Opportunistic Infection) 05/2016 - 07/2014
2	Autoimmune Lymphoproliferative Syndrome 01/2016 - 08/2006
1	Clinical Deterioration 01/2023
1	Down Syndrome (Down's Syndrome) 01/2023
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2023
1	Leukemia 01/2022
1	Common Variable Immunodeficiency 01/2022
1	Post-Acute COVID-19 Syndrome 10/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Parasitemia 10/2020
1	Malaria 10/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	GATA2 Deficiency 01/2017
1	Mycoses (Diseases, Fungus) 03/2016
1	Chronic Renal Insufficiency 01/2016
1	Clostridium Infections 08/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2014
1	Vascular Diseases (Vascular Disease) 12/2013
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2012
1	Stroke (Strokes) 06/2012
1	Hypoalbuminemia 06/2012
1	Atherosclerosis 06/2012
1	End Stage Liver Disease 08/2007
1	Tuberculosis (Tuberculoses) 09/2006
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 09/2006

Drug/Important Bio-Agent (IBA)

10	Immunoglobulin A (IgA)IBA 11/2020 - 01/2003
8	AntibodiesIBA 01/2022 - 06/2012
7	Antiphospholipid AntibodiesIBA 12/2023 - 01/2014
6	VaccinesIBA 01/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2016
4	CytokinesIBA 01/2023 - 01/2021
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2003
3	tocilizumab (atlizumab)FDA Link 04/2022 - 04/2021
3	BNT162 VaccineIBA 01/2022 - 01/2021
3	AntigensIBA 12/2021 - 09/2020
3	Glycoproteins (Glycoprotein)IBA 01/2014 - 06/2012
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
2	Neutralizing AntibodiesIBA 01/2022 - 12/2021
2	mRNA VaccinesIBA 01/2022 - 01/2021
2	Interleukin-2 (IL2)IBA 12/2021 - 01/2021
2	InterferonsIBA 12/2021 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 04/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
2	PerforinIBA 12/2020 - 09/2006
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2020 - 10/2009
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2017 - 07/2015
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2023
1	AndrogensIBA 01/2023
1	DioxygenasesIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Interferon Type IIBA 01/2023
1	polyglutamineIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2022
1	T-Independent Antigens (Antigens, T Independent)IBA 01/2022
1	Viral AntigensIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	SteroidsIBA 10/2021
1	ChromatinIBA 09/2021
1	HLA-DR Antigens (HLA-DR)IBA 09/2021
1	Interleukin-10 (Interleukin 10)IBA 09/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2021
1	Methylprednisolone FDA LinkGeneric 04/2021
1	mesoglycanIBA 01/2021
1	daratumumabIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	EpitopesIBA 10/2020
1	Peptides (Polypeptides)IBA 09/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2020
1	GATA2 Transcription FactorIBA 01/2017
1	CreatinineIBA 01/2016
1	Caspase 10IBA 01/2016
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 07/2015
1	Complement System Proteins (Complement)IBA 06/2012

Therapy/Procedure

9	Kidney Transplantation 01/2018 - 01/2014
6	Transplantation 12/2020 - 10/2009
5	Therapeutics 04/2022 - 04/2021
3	Liver Transplantation 01/2021 - 08/2007
2	Organ Transplantation 05/2016 - 03/2016
1	Renal Dialysis (Hemodialysis) 01/2023
1	Critical Care (Surgical Intensive Care) 09/2021
1	Immunomodulation 04/2021
1	Salvage Therapy 04/2021
1	Cell Transplantation 06/2012
1	Catheters 06/2012